Outputs (2)

Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: Phase III randomised placebo controlled trial (MIR) (2018)
Journal Article
Kessler, D. S., MacNeill, S. J., Tallon, D., Lewis, G., Peters, T. J., Hollingworth, W., Round, J., Burns, A., Chew-Graham, C. A., Anderson, I. M., Shepherd, T., Campbell, J., Dickens, C. M., Carter, M., Jenkinson, C., Macleod, U., Gibson, H., Davies, S., & Wiles, N. J. (2018). Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: Phase III randomised placebo controlled trial (MIR). BMJ, 363, Article k4218. https://doi.org/10.1136/bmj.k4218

Objective: To investigate the effectiveness of combining mirtazapine with Serotonin-Noradrenaline Reuptake Inhibitor (SNRI) or Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants for patients in primary care who had not responded to an anti... Read More about Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: Phase III randomised placebo controlled trial (MIR).

Embedding electronic decision-support tools for suspected cancer in primary care: a qualitative study of GPs' experiences (2015)
Journal Article
Dikomitis, L., Green, T., & Macleod, U. (2015). Embedding electronic decision-support tools for suspected cancer in primary care: a qualitative study of GPs' experiences. Primary health care research & development, 16(6), 548-555. https://doi.org/10.1017/S1463423615000109

Aim: The purpose of this evaluation was to obtain views from general practitioners (GPs) who piloted the electronic risk assessment tools (eRATs) for suspected lung or colorectal cancer. We wanted to find out whether GPs were able to integrate these... Read More about Embedding electronic decision-support tools for suspected cancer in primary care: a qualitative study of GPs' experiences.